|
|
||||||||
Clinical Chemistry, Vol 22, 785-788, Copyright © 1976 by American Association for Clinical Chemistry
LC Falk, DR Clark, SM Kalman and TF Long
We describe an assay for methotrexate in biological fluids. The assay is based on inhibition by methotrexate of dihydrofolate reductase from Lactobacillus casei. The lower limit of sensitivity in serum is 2 X 10(- 8) mol (about 10 mug) of methotrexate per liter. Within-run precision is +/- 5% (coefficient of variation) and day-to-day variation is 18%. Advantages of the assay are ease of manipulation, high sensitivity, and specificity.
The following articles in journals at HighWire Press have cited this article:
![]() |
L. R. Belur, D. Boelk-Galvan, M. D. Diers, R. S. McIvor, and C. L. Zimmerman Methotrexate Accumulates to Similar Levels in Animals Transplanted with Normal versus Drug-resistant Transgenic Marrow Cancer Res., February 1, 2001; 61(4): 1522 - 1526. [Abstract] [Full Text] |
||||
![]() |
B. C. Widemann, F. M. Balis, and P. C. Adamson Dihydrofolate Reductase Enzyme Inhibition Assay for Plasma Methotrexate Determination Using a 96-Well Microplate Reader Clin. Chem., February 1, 1999; 45(2): 223 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Balis, J. S. Holcenberg, D. G. Poplack, J. Ge, H. N. Sather, R. F. Murphy, M. M. Ames, M. J. Waskerwitz, D. G. Tubergen, S. Zimm, et al. Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children's Cancer Group and Pediatric Oncology Branch Study Blood, November 15, 1998; 92(10): 3569 - 3577. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |